Northwest Biotherapeutics announced that it is expanding its Board of Directors through the appointment of Ms. Susan Bayh and Ambassador Cofer Black as independent Directors. Neither Ms. Bayh nor Ambassador Black has worked with the company previously. Bayh brings to NW Bio 25 years of experience relating to the pharmaceutical and biotech industries, including in immunotherapies for cancer.

She has served on the Boards of Wellpoint, Inc., as well as on the board of eight public biotech companies, and three other companies, including in multiple leadership positions.